PP
ABBV icon

PFS Partners’s AbbVie ABBV Stock Holding History

PFS Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$471K Buy
1,870
+745
+66% +$160K 0.19% 53
2026
Q1 		$245K Sell
1,125
-52
-4% -$11.5K 0.11% 79
2025
Q4 		$269K Buy
1,177
+2
+0.2% +$456 0.12% 69
2025
Q3 		$272K Buy
1,175
+15
+1% +$3.06K 0.13% 60
2025
Q2 		$215K Buy
1,160
+50
+5% +$9.29K 0.11% 64
2025
Q1 		$233K Buy
1,110
+2
+0.2% +$389 0.12% 60
2024
Q4 		$197K Buy
1,108
+3
+0.3% +$552 0.11% 70
2024
Q3 		$218K Sell
1,105
-115
-9% -$21.5K 0.12% 57
2024
Q2 		$209K Buy
1,220
+3
+0.2% +$497 0.13% 59
2024
Q1 		$222K Buy
1,217
+103
+9% +$17.8K 0.15% 54
2023
Q4 		$173K Buy
1,114
+145
+15% +$21.1K 0.12% 60
2023
Q3 		$144K Buy
969
+4
+0.4% +$587 0.13% 54
2023
Q2 		$130K Buy
965
+253
+36% +$37.1K 0.11% 58
2023
Q1 		$113K Sell
712
-28
-4% -$4.28K 0.11% 58
2022
Q4 		$120K Buy
740
+2
+0.3% +$307 0.13% 53
2022
Q3 		$99.1K Buy
738
+2
+0.3% +$287 0.11% 55
2022
Q2 		$113K Sell
736
-14
-2% -$2.14K 0.11% 54
2022
Q1 		$122K Sell
750
-35
-4% -$5.08K 0.11% 57
2021
Q4 		$106K Buy
+785
New +$92.7K 0.08% 69

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PFS Partners's ABBV Position: Q2 2026 in Review

PFS Partners increased its AbbVie (ABBV) stake by 66% in Q2 2026, buying an estimated $160K and bringing the position to 1,870 shares worth $471K. The position accounts for 0.19% of the portfolio, ranked #53.

PFS Partners first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • PFS Partners held 1,870 shares of AbbVie worth $471K as of Q2 2026.
  • PFS Partners bought 745 AbbVie shares in Q2 2026, an estimated $160K.
  • AbbVie made up 0.19% of PFS Partners's portfolio in Q2 2026, its #53 holding.
  • PFS Partners first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • 4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on PFS Partners's 13F filing for Q2 2026, filed 20 Jul 2026.